Hookipa Pharma Inc Expected To Post A Loss Of 21 Cents A Share: Earnings Preview

Hookipa Pharma

13/03/2023 14:24

* HOOKIPA Pharma Inc  HOOK.OQ   HOOK.O  is expected to show
a rise
in quarterly revenue when it reports  results on March 15. 
    * The New York City-based  company is expected to report  a
81.5% increase in revenue to $7.069 million from $3.9 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for HOOKIPA Pharma Inc
is for
a loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $5​, above​ its last closing price of $0.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.29       -0.28      -0.25     Beat    11.2
 Jun. 30 2022  -0.36       -0.36      -0.23     Beat    36.1
 Mar. 31 2022  -0.24       -0.24      -0.40     Missed  -66.7​
 Dec. 31 2021  -0.63       -0.58      -0.65     Missed  -12.3
 ​​Sep.        -0.52       -0.52      -0.61     Missed  -16.6
 30 2021                                                
 Jun. 30 2021  -0.53       -0.53      -0.52     Beat    1.6​
 Mar. 31 2021  -0.52       -0.53      -0.53     Met     0.6
 Dec. 31 2020  -0.54       -0.58      -0.46     Beat    21.4
 This summary was machine generated March 13 at 14:24 GMT.  All
figures in US dollars  unless otherwise stated